- Home
- Publications
- Publication Search
- Publication Details
Title
SRC-Family Kinases in Acute Myeloid Leukaemia and Mastocytosis
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 7, Pages 1996
Publisher
MDPI AG
Online
2020-07-22
DOI
10.3390/cancers12071996
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Midostaurin improves quality of life and mediator–related symptoms in advanced systemic mastocytosis
- (2020) Karin Hartmann et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Targeting FLT3 mutations in AML: review of current knowledge and evidence
- (2019) Naval Daver et al. LEUKEMIA
- Oncogenic D816V-KIT signaling in mast cells causes persistent IL-6 production
- (2019) Araceli Tobío et al. HAEMATOLOGICA
- Expression of myeloid Src-family kinases is associated with poor prognosis in AML and influences Flt3-ITD kinase inhibitor acquired resistance
- (2019) Ravi K. Patel et al. PLoS One
- Selective Inhibition of the Myeloid Src-Family Kinase Fgr Potently Suppresses AML Cell Growth in Vitro and in Vivo
- (2018) Mark C. Weir et al. ACS Chemical Biology
- Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial
- (2018) Peter Paschka et al. LEUKEMIA
- Src family kinase inhibitor bosutinib enhances retinoic acid-induced differentiation of HL-60 leukemia cells
- (2018) Robert J. MacDonald et al. LEUKEMIA & LYMPHOMA
- Heterogeneous prognosis among KIT mutation types in adult acute myeloid leukemia patients with t(8;21)
- (2018) Ya-Zhen Qin et al. Blood Cancer Journal
- Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management
- (2018) Animesh Pardanani AMERICAN JOURNAL OF HEMATOLOGY
- Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia
- (2018) Jarno L. Kivioja et al. LEUKEMIA
- The role of SRC family kinases in FLT3 signaling
- (2018) Julhash U. Kazi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- D816V mutation in the KIT gene activation loop has greater cell-proliferative and anti-apoptotic ability than N822K mutation in core-binding factor acute myeloid leukemia
- (2017) Ikuko Omori et al. EXPERIMENTAL HEMATOLOGY
- Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study
- (2017) Olivier Lortholary et al. LANCET
- Next-generation sequencing and molecular cytogenetic characterization of ETV6-LYN fusion due to chromosomes 1, 8 and 12 rearrangement in acute myeloid leukemia
- (2017) Edmond S.K. Ma et al. Cancer Genetics
- Palbociclib treatment of FLT3-ITD+ AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6
- (2016) I. Z. Uras et al. BLOOD
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts
- (2016) Peter Valent et al. BLOOD
- Lineage-specific STAT5 target gene activation in hematopoietic progenitor cells predicts the FLT3+-mediated leukemic phenotype
- (2016) T A Müller et al. LEUKEMIA
- Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis
- (2016) Jason Gotlib et al. NEW ENGLAND JOURNAL OF MEDICINE
- An essential pathway links FLT3-ITD, HCK and CDK6 in acute myeloid leukemia
- (2016) Sophie Lopez et al. Oncotarget
- FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia
- (2016) Rohit A. Chougule et al. Oncotarget
- Bosutinib, a Lyn/Btk inhibiting tyrosine kinase inhibitor, is ineffective in advanced systemic mastocytosis
- (2015) Nicole Randall et al. AMERICAN JOURNAL OF HEMATOLOGY
- Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors
- (2015) Robert Roskoski PHARMACOLOGICAL RESEARCH
- SYK Is a Critical Regulator of FLT3 in Acute Myeloid Leukemia
- (2014) Alexandre Puissant et al. CANCER CELL
- Mast cell activation: A complex interplay of positive and negative signaling pathways
- (2014) Riccardo Sibilano et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Molecular Editing of Cellular Responses by the High-Affinity Receptor for IgE
- (2014) R. Suzuki et al. SCIENCE
- The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents
- (2013) C. Dos Santos et al. BLOOD
- The C-Kit Receptor-Mediated Signal Transduction and Tumor-Related Diseases
- (2013) Jing Liang et al. International Journal of Biological Sciences
- KIT-D816V oncogenic activity is controlled by the juxtamembrane docking site Y568-Y570
- (2013) A Chaix et al. ONCOGENE
- A Pyrrolo-Pyrimidine Derivative Targets Human Primary AML Stem Cells in Vivo
- (2013) Y. Saito et al. Science Translational Medicine
- Development of a Highly Selective c-Src Kinase Inhibitor
- (2012) Kristoffer R. Brandvold et al. ACS Chemical Biology
- SRC is a signaling mediator in FLT3-ITD- but not in FLT3-TKD-positive AML
- (2012) H. Leischner et al. BLOOD
- Functions of the Lyn tyrosine kinase in health and disease
- (2012) Evan Ingley Cell Communication and Signaling
- Stem Cell Factor Receptor/c-Kit: From Basic Science to Clinical Implications
- (2012) Johan Lennartsson et al. PHYSIOLOGICAL REVIEWS
- The Fyn-STAT5 Pathway: A New Frontier in IgE- and IgG-Mediated Mast Cell Signaling
- (2012) Nicholas A. Pullen et al. Frontiers in Immunology
- Transmembrane Adaptor Proteins in the High-Affinity IgE Receptor Signaling
- (2012) Petr Draber et al. Frontiers in Immunology
- KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib
- (2011) K. V. Gleixner et al. BLOOD
- The Src Family Kinase Fgr Is Critical for Activation of Mast Cells and IgE-Mediated Anaphylaxis in Mice
- (2011) J. H. Lee et al. JOURNAL OF IMMUNOLOGY
- Balanced Interactions between Lyn, the p85 Regulatory Subunit of Class IA Phosphatidylinositol-3-Kinase, and SHIP Are Essential for Mast Cell Growth and Maturation
- (2011) P. Ma et al. MOLECULAR AND CELLULAR BIOLOGY
- Targeting Src family kinases in anti-cancer therapies: turning promise into triumph
- (2011) Siyuan Zhang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Dasatinib impairs long-term expansion of leukemic progenitors in a subset of acute myeloid leukemia cases
- (2010) Lina Han et al. ANNALS OF HEMATOLOGY
- Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations
- (2010) Y. Yang et al. BLOOD
- Dasatinib Inhibits the Growth of Molecularly Heterogeneous Myeloid Leukemias
- (2010) B. S. Guerrouahen et al. CLINICAL CANCER RESEARCH
- Mast cell homeostasis and the JAK–STAT pathway
- (2010) J K Morales et al. GENES AND IMMUNITY
- Mechanisms of STAT Protein Activation by Oncogenic KIT Mutants in Neoplastic Mast Cells
- (2010) Amandine Chaix et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- FES kinases are required for oncogenic FLT3 signaling
- (2010) E Voisset et al. LEUKEMIA
- Identification of Therapeutic Targets for Quiescent, Chemotherapy-Resistant Human Leukemia Stem Cells
- (2010) Y. Saito et al. Science Translational Medicine
- Expression of Activated STAT5 in Neoplastic Mast Cells in Systemic Mastocytosis
- (2009) Christian Baumgartner et al. AMERICAN JOURNAL OF PATHOLOGY
- The tyrosine kinase network regulating mast cell activation
- (2009) Alasdair M. Gilfillan et al. IMMUNOLOGICAL REVIEWS
- The D816V Mutation of c-Kit Circumvents a Requirement for Src Family Kinases in c-Kit Signal Transduction
- (2009) Jianmin Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Minor Catalytic Activity of Src Family Kinases Is Sufficient for Maximal Activation of Mast Cells via the High-Affinity IgE Receptor
- (2009) Michael Poderycki et al. JOURNAL OF IMMUNOLOGY
- Identification of a novel TEL–Lyn fusion gene in primary myelofibrosis
- (2009) H Tanaka et al. LEUKEMIA
- Dasatinib promotes ATRA-induced differentiation of AML cells
- (2009) P L Kropf et al. LEUKEMIA
- Src kinases as therapeutic targets for cancer
- (2009) Lori C. Kim et al. Nature Reviews Clinical Oncology
- Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
- (2009) Patrice Dubreuil et al. PLoS One
- High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia
- (2008) M. M. Loriaux et al. BLOOD
- Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia
- (2008) M. H. Tomasson et al. BLOOD
- Gab2 Is Involved in Differential Phosphoinositide 3-Kinase Signaling by Two Splice Forms of c-Kit
- (2008) Jianmin Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Src family kinases promote AML cell survival through activation of signal transducers and activators of transcription (STAT)
- (2008) Yukiyasu Ozawa et al. LEUKEMIA RESEARCH
- Src family kinases: Regulation of their activities, levels and identification of new pathways
- (2007) Evan Ingley BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Kit- and FcɛRI-induced differential phosphorylation of the transmembrane adaptor molecule NTAL/LAB/LAT2 allows flexibility in its scaffolding function in mast cells
- (2007) Shoko Iwaki et al. CELLULAR SIGNALLING
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started